Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-estrogen plus progestin containing oral contraceptives

Anti-estrogen plus progestin containing oral contraceptives

US Patent 6326392 · Granted Dec 4, 2001

Estimated economic value: $212,300,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-cancer nuclear hormone receptor-targeting compounds2024
Anti-cancer nuclear hormone receptor-targeting compounds2024
Anti-cancer nuclear hormone receptor-targeting compounds2023
Indazoles2009
Quinolines and pharmaceutical compositions thereof2009
6-Hydroxyequilenins as estrogenic agents2007
Substituted 2-phenyl benzofurans as estrogenic agents2006
Substituted 2-phenyl benzofurans as estrogenic agents2004
Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents2003
5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as 2003
Oral contraceptive2002
Combination therapy for inhibiting sphincter incontinence2002